SCHEMBL316626

SCHEMBL316626

NNC(=O)c1cccc(Cl)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.63
ALDH1A1 P00352 2/20 0.63
PARP1 P09874 1/20 0.62
L3MBTL1 Q9Y468 2/20 0.59
LMNA P02545 1/20 0.59
MAPT P10636 1/20 0.59
KCNK3 O14649 1/20 0.57
KCNK9 Q9NPC2 1/20 0.57
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
ERCC5 P28715 1/20 0.56
FEN1 P39748 1/20 0.56
KCNMA1 Q12791 1/20 0.56
PKM P14618 2/20 0.55
RAB9A P51151 2/20 0.55
ATM Q13315 1/20 0.55
AOC2 O75106 1/20 0.54
FLT1 P17948 1/20 0.54
FLT4 P35916 1/20 0.54
KDR P35968 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31242942 1.00 KDM4E (0.63) KDM4EALDH1A1PARP1L3MBTL1LMNA
Hydrochloric Acid SCHEMBL15137104 0.98 KDM4E (0.61) KDM4EALDH1A1PARP1L3MBTL1LMNA
Cyanide SCHEMBL29178066 0.94 KDM4E (0.58) KDM4EALDH1A1PARP1L3MBTL1LMNA
SCHEMBL5353587 0.88 KCNK3 (0.72) KCNK3KCNK9MEN1KMT2ARAB9A
SCHEMBL10441487 0.86 S1PR1 (0.51) KDM4EALDH1A1PARP1L3MBTL1LMNA
SCHEMBL77384 0.85 ALDH1A1 (0.76) KDM4EALDH1A1L3MBTL1LMNAMAPT
SCHEMBL3717147 0.85 KMT2A (0.60) ALDH1A1LMNAMAPTMEN1KMT2A
SCHEMBL7174674 0.83 MEN1 (0.70) ALDH1A1PARP1L3MBTL1KCNK3KCNK9
SCHEMBL11064749 0.83 PKM (0.67) KDM4EALDH1A1PARP1L3MBTL1KCNK3
SCHEMBL47363 0.83 CA1 (0.57) ALDH1A1PARP1L3MBTL1KCNK3KCNK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 535 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119977832-A Benzoyl hydrazine antineoplastic compound and preparation method and application thereof 江苏海洋大学 2025-05-13 CN claimed
CN-117402125-A Preparation method of noo Bo Suan oxadiazole thioester compound, product and application thereof 南京林业大学 2024-01-16 CN claimed
CN-109369560-A Using DMF as one step of carbon source construct 2-(3- chlorphenyl) -1,3,4- oxadiazoles method 桂林理工大学 2019-02-22 CN claimed
EP-1392219-A4 SUBSTITUTED N'-(ARYLCARBONYL)-BENZHYDRAZIDES, N'-(ARYLCARBONYL)-BENZYLIDENE-HYDRAZIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOTOSIS AND THE USE THEREOF CYTOVIA INC (US) 2007-01-24 EP claimed
US-20040186078-A1 Substituted N'-(arylcarbonyl)-benzhydrazides, N'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof CYTOVIA, INC. 2004-09-23 US claimed
US-6716859-B2 ANTICANCER AGENTS CYTOVIA, INC. 2004-04-06 US claimed
EP-1392219-A2 SUBSTITUTED N'-(ARYLCARBONYL)-BENZHYDRAZIDES, N'-(ARYLCARBONYL)-BENZYLIDENE-HYDRAZIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOTOSIS AND THE USE THEREOF Cytovia, Inc. (US) 2004-03-03 EP claimed
US-20030105140-A1 Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof CYTOVIA, INC. 2003-06-05 US claimed
US-20030013743-A1 Substituted N'-(arylcarbonyl)-benzhydrazides, N'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof CYTOVIA, INC. 2003-01-16 US claimed
WO-2002102301-A2 SUBSTITUTED INDOLE-2-CARBOXYLIC ACID BENZYLIDENE-HYDRAZIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF CYTOVIA, INC. (US) 2002-12-27 WO claimed
WO-2002089745-A2 SUBSTITUTED N'-(ARYLCARBONYL)-BENZHYDRAZIDES, N'-(ARYLCARBONYL)-BENZYLIDENE-HYDRAZIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF CYTOVIA, INC. (US) 2002-11-14 WO claimed
US-20020128292-A1 Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof CYTOVIA, INC. 2002-09-12 US claimed
EP-0236646-B1 ORTHO-ANISAMIDES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL APPLICATIONS Laboratoires DELAGRANGE, Société Anonyme (FR) 1990-10-10 EP claimed
EP-0236646-A1 Ortho-anisamides, process for their preparation and their pharmaceutical applications Laboratoires DELAGRANGE, Société Anonyme (FR) 1987-09-16 EP claimed
CN-86105682-A Novel benzamides, process for their preparation and their use in therapy 1987-02-04 CN claimed
US-12478621-B2 Substituted aminoquinolones as dgkalpha inhibitors for immune activation DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2025-11-25 US disclosed
CN-119977832-A Benzoyl hydrazine antineoplastic compound and preparation method and application thereof 江苏海洋大学 2025-05-13 CN disclosed
EP-0080296-A1 Pharmaceutically active phenyl-thia-, oxa- or triazinones IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1983-06-01 EP disclosed
US-4309422-A INSECTICIDES VELSICOL CHEMICAL CORPORATION (US) 1982-01-05 US disclosed
US-4071633-A Fungicidal N-trichloroacetyl-N'-chlorobenzoylhydrazine derivatives KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JA) 1978-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128292-A1 Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof BAD, API5, CASP2 KDM4E 2887/4885ALDH1A1 144/4885PARP1 100/4885
US-20030105140-A1 Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof BAD, API5, CASP2 KDM4E 2887/4885ALDH1A1 144/4885PARP1 100/4885
US-20040186078-A1 Substituted N'-(arylcarbonyl)-benzhydrazides, N'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof CASP2, CASP1, BCL2 KDM4E 2863/4885ALDH1A1 140/4885PARP1 48/4885
US-12478621-B2 Substituted aminoquinolones as dgkalpha inhibitors for immune activation DGKK, DGKG, DGKA KDM4E 1315/4885ALDH1A1 3915/4885PARP1 1779/4885
US-20030013743-A1 Substituted N'-(arylcarbonyl)-benzhydrazides, N'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof CASP2, CASP1, BCL2 KDM4E 2863/4885ALDH1A1 140/4885PARP1 48/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.